YAP1 and breast carcinoma: Notably, we discovered novel miRNAs that target MDM4 and MDM2; this study enhances our understanding of the YAP1/Hippo pathway and the functions of miRNAs as novel therapeutic targets in breast cancer (Fig. 7).